- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05794685
The Analgesic Efficacy of Ultrasound Guided Adductor Canal Block Versus 4 in 1 Block in Patients Undergoing Knee Surgeries: A Comparative Randomized Double Blinded Study . (No acronym)
July 28, 2023 updated by: Mahmoud Hussein Bahr
Knee surgeries are associated with severe postoperative pain.
Improper pain management affects patients' psychological status with prolongation of hospital stay time and rehabilitation period, with the possibility of progression of the acute pain to chronic pain (McCartney CJ, Nelligan K., 2014).
Many Pain management options following these surgeries are available: non-opioid analgesics, opioids and regional anesthesia techniques (epidural and peripheral nerve block).
Multi-modal analgesia is considered the best option for pain management in knee surgeries.
As non-opioid analgesics alone are not effective enough while opioids alone are associated with many risk factors: nausea, vomiting, decrease intestinal motility and respiratory depression with possibility of addiction (Goode VM, Morgan B, et al, 2019)
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
Knee surgeries are associated with severe postoperative pain.
Improper pain management affects patients' psychological status with prolongation of hospital stay time and rehabilitation period, with the possibility of progression of the acute pain to chronic pain (McCartney CJ, Nelligan K., 2014).
Many Pain management options following these surgeries are available: non-opioid analgesics, opioids and regional anesthesia techniques (epidural and peripheral nerve block).
Multi-modal analgesia is considered the best option for pain management in knee surgeries.
As non-opioid analgesics alone are not effective enough while opioids alone are associated with many risk factors: nausea, vomiting, decrease intestinal motility and respiratory depression with possibility of addiction (Goode VM, Morgan B, et al, 2019).
Regarding the functional anatomy of the nerve supply to knee joint: The knee is innervated by genicular branches from the nerve to vastus medialis, saphenous nerve, sciatic nerve and the posterior division of obturator nerve.
The skin around the knee is supplied by the cutaneous branches from the femoral nerve and the saphenous nerve (Ritesh Roy, Gaurav Agarwal, et al, 2018).
The widespread use of ultrasound to advance peripheral nerve block techniques over the past decade has led to enormous growth in the utilization and efficiency of regional anesthesia (Cozowicz, Crispiana & Poeran, et al, 2015).
The adductor canal block (ACB) is an interfascial plane block performed in the middle third of the medial side of the thigh.
The adductor canal bounded anteriorly by the sartorius muscle, posteriorly and medially by the adductor longus and magnus muscles, and laterally by the vastus medialis muscle.
It contains the femoral vein and artery, the saphenous nerve and the nerve to the vastus medialis, both are sensory branches of the femoral nerve.
In some individuals, the obturator sensory branch (also a femoral nerve branch) can be affected by local anesthetic infiltration into this area.
It can be noted that this block affect sensory branches and avoid blocking the majority of motor branches.
The block is most commonly performed using ultrasound guidance (Thiayagarajan MK, Kumar SV,et al 2019).
Ultrasound guided 4-in-1 block technique: a new single injection technique described by Roy R, Agarwal G, et al, 2018 for the combined 4 nerves (saphenous nerve, obturator nerve, nerve to vastus medialis and sciatic nerve) with a single injection point is located at the adductor hiatus where descending genicular artery branches from superficial femoral artery.
Bupivacaine is a long-acting amide local anesthetic (max.
dose 2.5 mg/kg).
Symptoms contributed to local anesthetic toxicity include tinnitus, perioral tingling, visual disturbances and dizziness (Shafiei FT, McAllister RK, Lopez J, 2022)
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mahmoud H Bahr
- Phone Number: Beni-Suef 00201004413095
- Email: mahmoud.mohamed1@med.bsu.edu.eg
Study Contact Backup
- Name: Shereen G Saad
- Phone Number: Beni-suef 00201155563450
- Email: Sherysaad33@gmail.com
Study Locations
-
-
-
Cairo, Egypt, 62511
- Faculty of medicine.Beni-suef university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Both sexes.
- ASA grade 1 and 2.
- Age group between 20-60 years.
- Patients who will undergo knee surgeries under neuroaxial anesthesia.
Exclusion criteria:
- Patient refusal.
- Patients who are allergic to any of study drugs.
- Absolute contraindication causes to spinal anesthesia due to coagulopathy, severe aortic/mitral stenosis, or active infection at site of injection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: adductor canal block
adductor canal block : patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg of dexamethasone at a point anterior to the femoral artery, deep to the sartorius muscle
|
patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg of dexamethasone at a point anterior to the femoral artery, deep to the sartorius muscle (adductor canal block).
patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg dexamethasone at the adductor hiatus where the descending genicular artery branches from superficial femoral artery (4 in one block).
|
Active Comparator: 4 in one block
4 in one block : patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg dexamethasone at the adductor hiatus where the descending genicular artery branches from superficial femoral artery .
|
patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg of dexamethasone at a point anterior to the femoral artery, deep to the sartorius muscle (adductor canal block).
patients will receive an injection of 30 ml of .25% of Bupivacaine including 4mg dexamethasone at the adductor hiatus where the descending genicular artery branches from superficial femoral artery (4 in one block).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative pain score: resting and dynamic .
Time Frame: 6 hours Postoperative
|
Postoperative pain score: resting and dynamic pain using NRS at postoperative 6 hours.Numerical rating scales (NRSs) are the simplest and most commonly used scales.
The numerical scale is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."
The patient picks (verbal version) or draws a circle around (written version) the number that best describes the pain dimension, usually intensity.
|
6 hours Postoperative
|
Postoperative pain score: resting and dynamic
Time Frame: 12 hours post operative
|
Postoperative pain score: resting and dynamic pain using NRS at postoperative 12 hours.
|
12 hours post operative
|
Postoperative pain score: resting and dynamic
Time Frame: 18 hours post operative
|
Postoperative pain score: resting and dynamic pain using NRS at postoperative 18 hours.
|
18 hours post operative
|
Postoperative pain score: resting and dynamic
Time Frame: 24 hours post operative.
|
Postoperative pain score: resting and dynamic pain using NRS at postoperative 24 hours.
|
24 hours post operative.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of blood pressure .
Time Frame: Intraoperative
|
Change of blood pressure (systolic, diastolic, mean pressure): Evaluation of the blood pressure before and 30min after applying the assigned block before receiving anesthesia.
Then, we will calculate the change of blood pressure at the two time points.
|
Intraoperative
|
Change of heart rate .
Time Frame: Intraoperative
|
Change of heart rate: Evaluation of the heart rate before and 30 min after applying the assigned block before receiving anesthesia.
Then, we will calculate the change of heart rate at the two time-points
|
Intraoperative
|
Postoperative opioid requirements .
Time Frame: 24 hours post operative
|
First time for opioid rescue and total dose in the frist 24 hours.
|
24 hours post operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2023
Primary Completion (Estimated)
December 1, 2023
Study Completion (Estimated)
January 1, 2024
Study Registration Dates
First Submitted
March 2, 2023
First Submitted That Met QC Criteria
March 20, 2023
First Posted (Actual)
April 3, 2023
Study Record Updates
Last Update Posted (Actual)
August 1, 2023
Last Update Submitted That Met QC Criteria
July 28, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- FMBSUREC/12022023/saad
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on adductor canal block
-
Benaroya Research InstituteCompletedPost-Operative PainUnited States
-
Karaman Training and Research HospitalCompletedOsteo Arthritis KneeTurkey
-
Lawson Health Research InstituteCompleted
-
Hospital for Special Surgery, New YorkRecruiting
-
University of PennsylvaniaCompletedOsteoarthritis | Total Knee Arthroplasty (TKA) | FallsUnited States
-
Seoul National University HospitalSeoul National UniversityCompletedPostoperative PainKorea, Republic of
-
University of California, Los AngelesCompleted
-
Asklepieion Voulas General HospitalChryssoula Staikou; Aikaterini KalampokiniUnknown
-
Cairo UniversityNot yet recruitingAdductor Canal Block
-
Wake Forest University Health SciencesCompletedPostoperative Analgesia | Medial Unicompartmental Knee ArthroplastyUnited States